2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Neoplasms
4
Breast Neoplasms
4
Melanoma
3
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Healthy Participants
2
Advanced Solid Tumor
2
cMET-dysregulated Advanced Solid Tumors
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Solid Tumor, Adult
1
Solid Tumor
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Liver Cirrhosis
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Head and Neck Neoplasms
1
Drug-drug Interaction,SHR3680
1
Colorectal Neoplasms
1
Advanced Solid Malignancies
1
Advanced Pancreatic Cancer
1
Interventions
Iodine-131
21
lenvatinib
17
Magnetic Resonance Spectroscopy
17
trametinib
13
Sorafenib
13
Thyrotropin Alfa
12
pembrolizumab
11
dabrafenib
11
Thyroidectomy
10
Surgical Procedures, Operative
10
Thyroxine
9
Paclitaxel
9
vandetanib
8
selpercatinib
8
Sunitinib
7
Nivolumab
7
Fluorodeoxyglucose F18
7
cabozantinib
6
anlotinib
6
Everolimus
6
Biopsy
6
pazopanib
5
Vemurafenib
5
Triiodothyronine
5
Specimen Handling
5
Saline Solution
5
Radiotherapy
5
Radiofrequency Ablation
5
Iodine-124
5
Cyclophosphamide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Digoxin
×
Clear all
NCT05507775
2024-04-11
DIGUP-TC
Radboud University Medical Center
Phase NA
Completed
8 enrolled